Answers are grounded in this paper and cite their sources.
Sarcopenia is common in patients with CKD, particularly in the most advanced stages of the disease. We observed an association between the levels of inflammatory markers and peripheral lean body mass, physical performance, and BMI. This association between sarcopenia and modifiable factors highlights the importance of early diagnosis and the implementation of therapeutic measures to minimize adverse outcomes in patients with CKD not yet on dialysis.
No takes yet. Share an insight, caveat, or question.
Souza et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: